2nd Quarter - Report

W STRATEGIES, LLC for GENZYME CORPORATION

Period 2nd Quarter 2012 Filed Jul 19, 2012 Signed by Darren Willcox, Manager

Official filing
Firm
W STRATEGIES, LLC
Client
GENZYME CORPORATION
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 5651: Food and Drug Administration Reform Act of 2012. S. 3187: Food and Drug Administration Safety and Innovation Act of 2012. H.R. 4132: Faster Access to Specialized Treatments Act.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 4132 (112th), S. 3187 (112th), H.R. 5651 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.